Hence, the EGFR inhibitors with the inhibitory effect on HB-EGF can be used in the combination with IL-6 monoclonal antibody or dexamethasone to achieve better therapeutic effects for MM [31, 32]. The gene discussed is IL6; the disease is Miyoshi myopathy.